CEO at Carcinotech
Ishani Malhotra, Chief Executive Officer, and founder of Carcinotech, has eight years’ experience in oncology and stem cell research with degrees from University of Edinburgh and a Certificate of Achievement from Harvard Medical School. She was listed as a Director of the Year Regional finalist at the Institute of Directors Scotland 2021 awards, has won several awards at national and international platforms and was recently recognised as one of 35 Rising Stars by Scottish Business Insider under 35. She has established significant international partnerships to advance Carcinotech’s vision of providing personalised drug testing platforms to help those suffering from cancer. Carcinotech manufactures 3D printed living tumours using patient biopsies to provide a platform for rapid, ethical, sustainable, and accurate drug screening, and personalised medicine testing.